ALLZITAL
NDC 68047-752, butalbital and acetaminophen, tablet, from Larken Laboratories, Inc..
- Product NDC
- 68047-752
- Status
- Listed
- Labeler
- Larken Laboratories, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203484
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/68047-752 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUTALBITAL25 mg/1
- ACETAMINOPHEN325 mg/1
Pharmacologic classes
Barbiturate [EPC]; Barbiturates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68047-752-01 | 68047075201 | 100 TABLET in 1 BOTTLE (68047-752-01) |
| 68047-752-30 | 68047075230 | 30 TABLET in 1 BOTTLE (68047-752-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/326c83fc-afed-45ad-9c87-f47968fa1d2a
Use it
Look up 68047-752 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68047-752 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68047-752. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.